MedTech Association to Bring HP Executive to Syracuse
Thursday, October 20, 2016
MedTech Association, a membership based trade association for the bioscience and medical technology (Bio/Med) industry in New York State (NYS), is excited to bring Dr. Ali Tinazli, Global Head of Healthcare and Life Sciences Strategy, HP, to Syracuse for the association’s third annual Connected Care Exchange (CCX) Conference. The 2016 CCX Conference is scheduled for Thursday, Nov. 3 from 12:30 – 5:00 at the CNY Biotech Accelerator, 841 East Fayette St., Syracuse, NY 13210.
MedTech’s third annual CCX conference focuses on today’s wireless healthcare environment. As the industry transitions to accountable care, connected care offers tremendous opportunities to help meet the need to contain cost inflation, improve clinical efficiencies and meet the demands of demographic trends.
This half day program will feature two panels on pressing digital health topics, including the future of medical technology and clinical care applications. Dr. Tinazli’ s keynote presentation, Blended Reality for Life, will discuss the convergence of microfluidics, commercial mobility and compute technologies for new applications in healthcare. He will also give an inside look at HP’s innovation strategy, focusing on a new microfluidic diagnostic prototype that looks to address the healthcare industry on a global level.
“We are so thrilled to bring Dr. Tinazli to Syracuse,” said Jessica Crawford, president of MedTech Association. “Biomedical, digital and electronic devices, health services and software and internet services have been classified as key CNY industry concentrations. Regional companies, such as Welch Allyn, are also leveraging the convergence of medical technology and digital health through connected health to improve health outcomes. This conference is the perfect opportunity to showcase the talent in the greater Syracuse region and connect our region’s leaders with HP, a leading company in the digital health industry.”
Dr. Tinazli has a deep background in the science and business of biomedicine and healthcare. He has done extensive work in the field of molecular biology of aging and nanobiotechnology and has authored nearly 20 publications. In December 2015, Dr. Tinazli joined HP’s office in Palo Alto and is leading the corporate-wide, global strategy for Healthcare and Life Sciences. In addition to his bioscience and industry domain experience, Dr. Tinazli brings strong entrepreneurial experience and hands-on knowledge of the biosciences start-up community. He currently sits on the Advisory Board of a bioinformatics/computer processor company, and serves as a Board Member at various start-up companies in the biomedical/digital health space.